Article Details

Deciphera Pharmaceuticals (NASDAQ:DCPH) Rating Increased to Buy at Zacks Investment ...

Retrieved on: 2021-01-15 18:22:30

Tags for this article:

Click the tags to see associated articles and topics

Deciphera Pharmaceuticals (NASDAQ:DCPH) Rating Increased to Buy at Zacks Investment .... View article details on hiswai:

Excerpt

BlackRock Inc. now owns 3,259,572 shares of the company's stock valued at $167,216,000 after buying an additional 170,366 shares in the last quarter.

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up